Search academic texts

Information × Registration Number 0306U001073, 0103U008746 , R & D reports Title Phase III study of Atamestane plus Toremifene versus Letrozole in advanced breast cancer. popup.stage_title Дослідження 3 фази препарату Атаместан у поєднанні з Тореміфеном у порівнянні з Летрозолом при поширеному раці грудної залози Head Pуlуpenko M.I., Registration Date 24-01-2006 Organization Grigor'ev Institute for Medical Radiology popup.description2 Object of the research: patients with advanced breast cancer. Purpose of the research: to compare the efficacy of a new drug Atamestane and Toremifen according to survival, disease-free survival and quality of life. Methods of the research and equipment: clinical observations, radiology assessment of the dynamics of the tumor regression, biochemical and clinical laboratory tests. Results and their novelty: new information can be obtained when studying a new effective antitumor drug. Area of application: oncology. Product Description popup.authors popup.nrat_date 2020-04-02 Close